𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pneumocystis jiroveciisolates with dihydropteroate synthase mutations in patients with chronic bronchitis

✍ Scribed by E. Calderón; C. de la Horra; F. J. Medrano; A. López-Suárez; M. A. Montes-Cano; N. Respaldiza; J. Elvira-González; J. Martín-Juan; A. Bascuñana; J. M. Varela

Publisher
Springer
Year
2004
Tongue
English
Weight
93 KB
Volume
23
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutation analysis in patients with N-ace
Mutation analysis in patients with N-acetylglutamate synthase deficiency
✍ Johannes Häberle; Eva Schmidt; Silke Pauli; Joachim Gerhard Kreuder; Barbara Ple 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

N-acetylglutamate synthase (NAGS) is the key enzyme for the regulation of the hepatic urea cycle and is also highly expressed in kidney and gut. The reaction product, N-acetylglutamate, is an allosteric activator of carbamylphosphate synthetase 1 in the liver, catalyzing the initial step of ammonia

Two mutations in dihydrofolate reductase
Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine–pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria
✍ Ambrose O. Talisuna; Anne Nalunkuma-Kazibwe; Peter Langi; Theonest K. Mutabingwa 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 87 KB

The point mutations in the Plasmodium falciparum dihydrofolate reductase (dhfr) and the dihydropteroate synthase (dhps) genes that are linked to sulphadoxine-pyrimethamine (SP) resistance in vitro have been well characterised. To determine whether a few of these mutations could predict SP treatment